HUM vs RVTY
Humana vs Revvity — AI-powered side-by-side comparison
| Metric | HUM | RVTY |
|---|
| AI Score |
52
|
59
|
| Price |
$386.32
|
$122.99
|
| P/E Ratio |
35.57×
|
59.40×
|
| ROE |
6.7%
|
3.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
13.7%
|
52.1%
|
| Debt / Equity |
0.74×
|
0.46×
|
| Dividend Yield |
0.9%
|
0.2%
|
| RSI (14) |
47.3
|
75.3
|
| Beta |
0.74
|
1.072
|
| Expected Upside |
+12.9%
|
—
|
AI Committee View
Current Innellis committee reasoning for HUM versus RVTY.
RVTY leads by 7 points.
RVTY scores 59/100 (Buy) versus HUM at 52/100 (Watch).
HUM Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — current ratio of 0.01 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- News sentiment is positive (+0.20 across 30 articles, 14d) — News
Bear Case
- P/E of 36.1 is moderate-to-rich — Value
- EPS declining -19.0% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
RVTY Committee View
60% agreement
5 analysts
Positive signals support the current rating — news sentiment is positive (+0.30 across 10 articles, 14d). The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 55.1 is expensive by classic value standards — Value
- ROE of only 3.3% -- cheap may mean cheap for a reason — Value
- EPS declining -10.8% YoY despite any revenue growth — Growth